This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Official event dates: January 11–15, 2021
Post-show access until March 31, 2021

Chen Partner
Partner at Jones Day


Tony Chen is a former co-chair of the IP subcommittee of the American Chamber of Commerce in Shanghai and has represented clients in complex cross-border intellectual property matters relating to China since 2004. Multinational companies turn to Tony for protecting their IP rights in China's patent office and courts and for reducing IP risks in China-related technology transactions. Chinese clients enlist Tony for managing patent and trade secret litigation overseas and for licensing technology and creating IP assets on a worldwide basis.

Tony has led Jones Day's China IP team and local counsel in representing clients from a variety of industries in patent invalidation and infringement disputes before China's patent reexamination board and IP courts, including Celgene (pharmaceutical), Cree (semiconductor), SharkNinja (consumer electronics), Lowes (household goods), and Milliken (chemicals). He has guided western companies in navigating China's myriad regulations relating to technology import and export, high and new technology enterprises, cybersecurity, foreign patent filing, and human genetic materials. Tony has worked with Jones Day's litigators in the United States and Europe in representing Chinese companies in litigation involving patent infringement, ITC 337 investigation, trade secret misappropriation, and economic espionage prosecution.

Tony is a leader in public policy projects promoting strong IP protection in China. He is an advisory member of the U.S.-China IP Cooperation Dialogue organized by the U.S. Chamber of Commerce and Renmin University of China. He was an advisor to Shanghai Pudong New Area and Suzhou BioBay on the development of biotechnology industry.